BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Cheong J, Yun MJ, Kim J, Lim JS, Hyung WJ, Noh SH. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 2005;103:2383-90. [DOI: 10.1002/cncr.21074] [Cited by in Crossref: 137] [Cited by in F6Publishing: 106] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Choi BH, Song HS, An YS, Han SU, Kim JH, Yoon JK. Relation between fluorodeoxyglucose uptake and glucose transporter-1 expression in gastric signet ring cell carcinoma. Nucl Med Mol Imaging 2011;45:30-5. [PMID: 24899975 DOI: 10.1007/s13139-010-0058-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
2 Hwang SW, Lee DH. Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer? World J Gastroenterol. 2014;20:13775-13782. [PMID: 25320515 DOI: 10.3748/wjg.v20.i38.13775] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
3 Tang L, Wang XJ, Baba H, Giganti F. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and 18F-FDG PET/CT findings. Eur Radiol 2020;30:247-60. [PMID: 31392480 DOI: 10.1007/s00330-019-06370-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Smyth EC, Shah MA. Role of 18F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World J Gastroenterol. 2011;17:5059-5074. [PMID: 22171140 DOI: 10.3748/wjg.v17.i46.5059] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
5 Cui J, Zhao P, Ren Z, Liu B. Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric Disease. Medicine (Baltimore). 2015;94:e1356. [PMID: 26287421 DOI: 10.1097/MD.0000000000001356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
6 Lehmann K, Eshmuminov D, Bauerfeind P, Gubler C, Veit-haibach P, Weber A, Abdul-rahman H, Fischer M, Reiner C, Schneider P. 18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma. European Journal of Surgical Oncology (EJSO) 2017;43:196-202. [DOI: 10.1016/j.ejso.2016.08.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Serrano OK, Love C, Goldman I, Huang K, Ng N, Abraham T, Da Silva R, Friedmann P, Libutti SK, Kennedy TJ. The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review. J Surg Oncol. 2016;113:640-646. [PMID: 27115836 DOI: 10.1002/jso.24190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Shim JH, O JH, Oh SI, Yoo HM, Jeon HM, Park CH, Kim SH, Song KY. Clinical Significance of Incidental Colonic 18F-FDG Uptake on PET/CT Images in Patients with Gastric Adenocarcinoma. J Gastrointest Surg 2012;16:1847-53. [DOI: 10.1007/s11605-012-1941-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Jensen EH, Tuttle TM. Preoperative Staging and Postoperative Surveillance for Gastric Cancer. Surgical Oncology Clinics of North America 2007;16:329-42. [DOI: 10.1016/j.soc.2007.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
10 Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med. 2008;49 Suppl 2:24S-42S. [PMID: 18523064 DOI: 10.2967/jnumed.107.047258] [Cited by in Crossref: 411] [Cited by in F6Publishing: 353] [Article Influence: 31.6] [Reference Citation Analysis]
11 Yoon NR, Park JM, Jung HS, Cho YK, Lee IS, Choi M, Chung I, Song KY, Park CH. Usefulness of 18 F-fluoro-2-deoxyglucose Positron Emission Tomography in Evaluation of Gastric Cancer Stage. Korean J Gastroenterol 2012;59:347. [DOI: 10.4166/kjg.2012.59.5.347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Kajiya Y, Tani A, Shimaoka S, Tanaka S, Nakajo M. Early Gastric Cancer Detected by 2-Hour Delayed FDG PET With the Water Gastric Distention Method. Clinical Nuclear Medicine 2011;36:e192-3. [DOI: 10.1097/rlu.0b013e3182291f57] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Malibari N, Hickeson M, Lisbona R. PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers. PET Clin. 2015;10:311-326. [PMID: 26099669 DOI: 10.1016/j.cpet.2015.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
14 Park S, Ha S, Kwon HW, Kim WH, Kim TY, Oh DY, Cheon GJ, Bang YJ. Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication. J Nucl Med. 2017;58:899-904. [PMID: 28572288 DOI: 10.2967/jnumed.116.182675] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
15 Saito T, Ebihara Y, Li L, Shirosaki T, Iijima H, Tanaka K, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S. A novel laparoscopic near-infrared fluorescence spectrum system for photodynamic diagnosis of peritoneal dissemination in pancreatic cancer. Photodiagnosis Photodyn Ther 2021;33:102157. [PMID: 33348076 DOI: 10.1016/j.pdpdt.2020.102157] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lipham JC, Demeester TR. Preoperative diagnosis of lymph node metastasis: a dream? Gastric Cancer 2006;9:70-1. [DOI: 10.1007/s10120-006-0382-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Park K, Jang G, Baek S, Song H. Usefulness of Combined PET/CT to Assess Regional Lymph Node Involvement in Gastric Cancer. Tumori 2014;100:201-6. [DOI: 10.1177/030089161410000214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 5.7] [Reference Citation Analysis]
18 Ott K, Herrmann K, Schuster T, Langer R, Becker K, Wieder HA, Wester HJ, Siewert JR, zum Büschenfelde CM, Buck AK. Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer. Ann Surg Oncol. 2011;18:3316-3323. [PMID: 21537865 DOI: 10.1245/s10434-011-1743-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
19 Pak KH, Yun M, Cheong JH, Hyung WJ, Choi SH, Noh SH. Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology. J Surg Oncol. 2011;104:566-570. [PMID: 21671462 DOI: 10.1002/jso.21997] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
20 Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D'Ugo D. R0 resection in the treatment of gastric cancer: room for improvement. World J Gastroenterol 2010;16:3358-70. [PMID: 20632437 DOI: 10.3748/wjg.v16.i27.3358] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
21 Kameyama R, Yamamoto Y, Izuishi K, Takebayashi R, Hagiike M, Murota M, Kaji M, Haba R, Nishiyama Y. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2009;36:382-388. [PMID: 18985344 DOI: 10.1007/s00259-008-0970-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
22 Staniuk T, Zegarski W, Małkowski B, Jankowski M, Klag M, Pietrzak T. Evaluation of FLT-PET/CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer. Contemp Oncol (Pozn) 2013;17:165-70. [PMID: 23788985 DOI: 10.5114/wo.2013.34621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
23 Wang Y, Xiao H, Wu H, Yao C, He H, Wang C, Li W. G protein subunit α q regulates gastric cancer growth via the p53/p21 and MEK/ERK pathways. Oncol Rep 2017;37:1998-2006. [PMID: 28350126 DOI: 10.3892/or.2017.5500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
24 Zhang Z, Zheng B, Chen W, Xiong H, Jiang C. Accuracy of 18F-FDG PET/CT and CECT for primary staging and diagnosis of recurrent gastric cancer: A meta-analysis. Exp Ther Med 2021;21:164. [PMID: 33456531 DOI: 10.3892/etm.2020.9595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Leake PA, Cardoso R, Seevaratnam R, Lourenco L, Helyer L, Mahar A, Law C, Coburn NG. A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer 2012;15 Suppl 1:S38-47. [PMID: 21667136 DOI: 10.1007/s10120-011-0047-z] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
26 Cordin J, Lehmann K, Schneider PM. Clinical Staging of Adenocarcinoma of the Esophagogastric Junction. In: Schneider PM, editor. Adenocarcinoma of the Esophagogastric Junction. Berlin: Springer Berlin Heidelberg; 2010. pp. 73-83. [DOI: 10.1007/978-3-540-70579-6_6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Zhu Z, Li F, Zhuang H. Gastric distension by ingesting food is useful in the evaluation of primary gastric cancer by FDG PET. Clin Nucl Med. 2007;32:106-109. [PMID: 17242562 DOI: 10.1097/01.rlu.0000252181.76139.5e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ma Q, Xin J, Zhao Z, Guo Q, Yu S, Xu W, Liu C, Zhai W. Value of 18F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension. Eur J Radiol. 2013;82:e302-e306. [PMID: 23434453 DOI: 10.1016/j.ejrad.2013.01.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
29 Shigeoka H, Imamoto H, Nishimura Y, Shimono T, Furukawa H, Imamura H, Yasuda T, Shiozaki H. Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma. World J Gastrointest Oncol 2010;2:282-6. [PMID: 21160641 DOI: 10.4251/wjgo.v2.i6.282] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
30 Yun M. Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT. J Gastric Cancer. 2014;14:1-6. [PMID: 24765531 DOI: 10.5230/jgc.2014.14.1.1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
31 Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, Kanegae K, Inubushi M, Tamaki N, Kitagawa Y. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 2008;22:177-84. [DOI: 10.1007/s12149-007-0097-9] [Cited by in Crossref: 95] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
32 Kitajima K, Nakajo M, Kaida H, Minamimoto R, Hirata K, Tsurusaki M, Doi H, Ueno Y, Sofue K, Tamaki Y, Yamakado K. Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update. Nagoya J Med Sci 2017;79:527-43. [PMID: 29238109 DOI: 10.18999/nagjms.79.4.527] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
33 Grabinska K, Pelak M, Wydmanski J, Tukiendorf A, d'Amico A. Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer. World J Gastroenterol 2015;21:5901-9. [PMID: 26019454 DOI: 10.3748/wjg.v21.i19.5901] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
34 Pepek JM, Chino JP, Willett CG, Palta M, Blazer Iii DG, Tyler DS, Uronis HE, Czito BG. Preoperative chemoradiotherapy for locally advanced gastric cancer. Radiat Oncol 2013;8:6. [PMID: 23286735 DOI: 10.1186/1748-717X-8-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
35 Wu CX, Zhu ZH. Diagnosis and evaluation of gastric cancer by positron emission tomography. World J Gastroenterol. 2014;20:4574-4585. [PMID: 24782610 DOI: 10.3748/wjg.v20.i16.4574] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
36 Eary JF. PET imaging for Treatment Response in Cancer. PET Clin 2008;3:101-9. [PMID: 20011618 DOI: 10.1016/j.cpet.2008.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Choi JY, Shim KN, Kim SE, Jung HK, Jung SA, Yoo K. The clinical value of 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma. Korean J Gastroenterol 2014;64:340-7. [PMID: 25530585 DOI: 10.4166/kjg.2014.64.6.340] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ducloux T. Les indications de la TEP-TDM en oncologie digestive. Gastroentérologie Clinique et Biologique 2009;33:295-300. [DOI: 10.1016/j.gcb.2009.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Kim EY, Lee WJ, Choi D, Lee SJ, Choi JY, Kim BT, Kim HS. The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol. 2011;79:183-188. [PMID: 20226612 DOI: 10.1016/j.ejrad.2010.02.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
40 Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol. 2009;35:449-455. [PMID: 19147324 DOI: 10.1016/j.ejso.2008.11.010] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 6.5] [Reference Citation Analysis]
41 Li S, Zhao Z, Yang H, Wang D, Sun W, Li S, Zhang Z, Fu W. Construction and Validation of a Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer. Cancer Control 2021;28:10732748211027160. [PMID: 34155937 DOI: 10.1177/10732748211027160] [Reference Citation Analysis]
42 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
43 Ha TK, Choi YY, Song SY, Kwon SJ. F18-fluorodeoxyglucose-positron emission tomography and computed tomography is not accurate in preoperative staging of gastric cancer. J Korean Surg Soc. 2011;81:104-110. [PMID: 22066108 DOI: 10.4174/jkss.2011.81.2.104] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
44 Pelc Z, Skórzewska M, Rawicz-Pruszyński K, Polkowski WP. Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment-Oncological and Surgical Perspective. Cancers (Basel) 2021;13:2509. [PMID: 34065596 DOI: 10.3390/cancers13102509] [Reference Citation Analysis]
45 Tsirlis TD, Papastratis G, Masselou K, Tsigris C, Papachristodoulou A, Kostakis A, Nikiteas NI. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 2008;14:2691-701. [PMID: 18461654 DOI: 10.3748/wjg.14.2691] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
46 Na SJ, o JH, Park JM, Lee HH, Lee SH, Song KY, Choi MG, Park CH. Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer. Oncotarget 2016;7:63968-80. [PMID: 27564108 DOI: 10.18632/oncotarget.11574] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
47 Seevaratnam R, Cardoso R, McGregor C, Lourenco L, Mahar A, Sutradhar R, Law C, Paszat L, Coburn N. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer 2012;15 Suppl 1:S3-18. [PMID: 21837458 DOI: 10.1007/s10120-011-0069-6] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 11.0] [Reference Citation Analysis]
48 Sharma M, Rai P, Rameshbabu CS. Techniques of imaging of nodal stations of gastric cancer by endoscopic ultrasound. Endosc Ultrasound. 2014;3:179-190. [PMID: 25184125 DOI: 10.4103/2303-9027.138793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
49 Wang TB, Wang J, Wei XQ, Wei B, Dong WG. Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer. Asia Pac J Clin Oncol 2012;8:180-6. [PMID: 22524577 DOI: 10.1111/j.1743-7563.2011.01490.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
50 Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallböhmer D, Prenzel KL, Metzger R, Bollschweiler E, Hölscher AH. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Nucl Med Commun. 2010;31:532-538. [PMID: 20220543 DOI: 10.1097/mnm.0b013e32833823ac] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
51 Shimada H, Okazumi S, Koyama M, Murakami K. Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature. Gastric Cancer. 2011;14:13-21. [PMID: 21331531 DOI: 10.1007/s10120-011-0017-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
52 Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol. 2009;99:199-206. [PMID: 19142901 DOI: 10.1002/jso.21224] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
53 Russell MC, Mansfield PF. Surgical approaches to gastric cancer. J Surg Oncol. 2013;107:250-258. [PMID: 22674546 DOI: 10.1002/jso.23180] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
54 Howard BA, Wong TZ. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiol Clin North Am 2021;59:737-53. [PMID: 34392916 DOI: 10.1016/j.rcl.2021.06.001] [Reference Citation Analysis]
55 Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831. [PMID: 17084257 DOI: 10.1016/j.jacc.2006.03.069] [Cited by in Crossref: 519] [Cited by in F6Publishing: 373] [Article Influence: 34.6] [Reference Citation Analysis]
56 Xu H, Guo R, Xu W, Pan Y, Ma T. 18F-fluorodeoxyglucose positron emission tomography-computed tomography scan after gastric endoscopy in those who present with non-specific symptoms, is it necessary or not? South Asian J Cancer 2017;6:59-63. [PMID: 28702407 DOI: 10.4103/2278-330X.208853] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wiehr S, von Ahsen O, Röse L, Mueller A, Mannheim JG, Honndorf V, Kukuk D, Reischl G, Pichler BJ. Preclinical evaluation of a novel c-Met inhibitor in a gastric cancer xenograft model using small animal PET. Mol Imaging Biol 2013;15:203-11. [PMID: 22864665 DOI: 10.1007/s11307-012-0580-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
58 van ’t Sant I, Engbersen MP, Bhairosing PA, Lambregts DMJ, Beets-tan RGH, van Driel WJ, Aalbers AGJ, Kok NFM, Lahaye MJ. Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis. Eur Radiol 2020;30:3101-12. [DOI: 10.1007/s00330-019-06524-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
59 Clark CJ, Thirlby RC, Picozzi V, Schembre DB, Cummings FP, Lin E. Current problems in surgery: gastric cancer. Curr Probl Surg. 2006;43:566-670. [PMID: 17000267 DOI: 10.1067/j.cpsurg.2006.06.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
60 Le Roux PY, Duong CP, Cabalag CS, Parameswaran BK, Callahan J, Hicks RJ. Incremental diagnostic utility of gastric distension FDG PET/CT. Eur J Nucl Med Mol Imaging 2016;43:644-53. [PMID: 26487512 DOI: 10.1007/s00259-015-3211-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
61 Biffi R, Fazio N, Luca F, Chiappa A, Andreoni B, Zampino MG, Roth A, Schuller JC, Fiori G, Orsi F, Bonomo G, Crosta C, Huber O. Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. World J Gastroenterol 2010;16:868-74. [PMID: 20143466 DOI: 10.3748/wjg.v16.i7.868] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
62 Li J, Yan R, Lei J, Jiang C. Comparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysis. Abdom Imaging 2015;40:2660-6. [DOI: 10.1007/s00261-015-0418-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
63 Kwee RM, Kwee TC. Modern imaging techniques for preoperative detection of distant metastases in gastric cancer. World J Gastroenterol. 2015;21:10502-10509. [PMID: 26457011 DOI: 10.3748/wjg.v21.i37.10502] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
64 Wang Z, Chen JQ. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol. 2011;11:19. [PMID: 21385469 DOI: 10.1186/1471-230x-11-19] [Cited by in Crossref: 71] [Cited by in F6Publishing: 26] [Article Influence: 7.1] [Reference Citation Analysis]
65 Lee JH, Bae JS, Ryu KW, Lee JS, Park SR, Kim CG, Kook MC, Choi IJ, Kim YW, Park JG. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol. 2006;12:2588-2592. [PMID: 16688807 DOI: 10.3748/wjg.v12.i16.2588] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
66 Park JC, Lee JH, Cheoi K, Chung H, Yun MJ, Lee H, Shin SK, Lee SK, Lee YC. Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor. Eur J Nucl Med Mol Imaging 2012;39:1107-16. [PMID: 22526958 DOI: 10.1007/s00259-012-2116-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
67 Gauthé M, Richard-Molard M, Cacheux W, Michel P, Jouve JL, Mitry E, Alberini JL, Lièvre A; Fédération Francophone de Cancérologie Digestive (FFCD). Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers. Dig Liver Dis 2015;47:443-54. [PMID: 25766918 DOI: 10.1016/j.dld.2015.02.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
68 Cozzaglio L, Bottura R, Di Rocco M, Gennari L, Doci R. Sentinel lymph node biopsy in gastric cancer: possible applications and limits. Eur J Surg Oncol. 2011;37:55-59. [PMID: 21115231 DOI: 10.1016/j.ejso.2010.10.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
69 Hur H, Kim SH, Kim W, Song KY, Park CH, Jeon HM. The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma. World J Surg Oncol. 2010;8:86. [PMID: 20932345 DOI: 10.1186/1477-7819-8-86] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
70 Bosch KD, Chicklore S, Cook GJ, Davies AR, Kelly M, Gossage JA, Baker CR. Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment. Eur J Nucl Med Mol Imaging 2020;47:759-67. [PMID: 31377821 DOI: 10.1007/s00259-019-04429-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
71 Jeong J, Cho I, Kong E, Chun K, Jang B, Kim T, Kim S, Song S. Evaluation of hybrid PET/CT gastrography in gastric cancer. Nuklearmedizin 2013;52:107-12. [PMID: 23681152 DOI: 10.3413/Nukmed-0504-12-05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Schneider C, Simon T, Hero B, Uphoff US, Drebber U, Alakus H, Holinski-Feder E, Berthold F, Dietlein M, Schmidt MC. [18F]Fluorodeoxyglucose positron emission tomography/computed tomography-positive gastric adenocarcinoma in a 12-year-old girl with Peutz-Jeghers syndrome. J Clin Oncol 2012;30:e140-3. [PMID: 22493416 DOI: 10.1200/JCO.2011.39.7422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
74 Oh HH, Lee SE, Choi IS, Choi WJ, Yoon DS, Min HS, Ra YM, Moon JI, Kang YH. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer. J Surg Oncol 2011;104:530-3. [PMID: 21618250 DOI: 10.1002/jso.21985] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
75 Tsujimoto H, Sugasawa H, Ono S, Ichikura T, Yamamoto J, Hase K. Has the accuracy of preoperative diagnosis improved in cases of early-stage gastric cancer? World J Surg. 2010;34:1840-1846. [PMID: 20407771 DOI: 10.1007/s00268-010-0587-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
76 Hoshi H. Management of Gastric Adenocarcinoma for General Surgeons. Surg Clin North Am 2020;100:523-34. [PMID: 32402298 DOI: 10.1016/j.suc.2020.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
77 Kaneko Y, Murray WK, Link E, Hicks RJ, Duong C. Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer. J Nucl Med. 2015;56:523-529. [PMID: 25745094 DOI: 10.2967/jnumed.114.150946] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
78 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
79 Ott K, Lordick F, Herrmann K, Krause BJ, Schuhmacher C, Siewert JR. The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies. Gastric Cancer. 2008;11:1-9. [PMID: 18373171 DOI: 10.1007/s10120-007-0448-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
80 Boniface MM, Wani SB, Schefter TE, Koo PJ, Meguid C, Leong S, Kaplan JB, Wingrove LJ, McCarter MD. Multidisciplinary management for esophageal and gastric cancer. Cancer Manag Res. 2016;8:39-44. [PMID: 27217796 DOI: 10.2147/CMAR.S101169] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 4.6] [Reference Citation Analysis]
81 Hopkins S, Yang GY. FDG PET imaging in the staging and management of gastric cancer. J Gastrointest Oncol. 2011;2:39-44. [PMID: 22811826 DOI: 10.3978/j.issn.2078-6891.2010.004] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
82 Kim HW, Won KS, Song BI, Kang YN. Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer. Nucl Med Mol Imaging. 2015;49:135-142. [PMID: 26085859 DOI: 10.1007/s13139-015-0327-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
83 Wu Z, Zhao J, Gao P, Song Y, Sun J, Chen X, Ma B, Wang Z. Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis. BMC Cancer 2017;17:275. [PMID: 28415990 DOI: 10.1186/s12885-017-3271-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
84 Takebayashi R, Izuishi K, Yamamoto Y, Kameyama R, Mori H, Masaki T, Suzuki Y. [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer. J Exp Clin Cancer Res. 2013;32:34. [PMID: 23718763 DOI: 10.1186/1756-9966-32-34] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
85 Shoda H, Kakugawa Y, Saito D, Kozu T, Terauchi T, Daisaki H, Hamashima C, Muramatsu Y, Moriyama N, Saito H. Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy. Br J Cancer. 2007;97:1493-1498. [PMID: 18040274 DOI: 10.1038/sj.bjc.6604062] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
86 Chung HW, Lee EJ, Cho YH, Yoon SY, So Y, Kim SY, Lee MH, Kim JH, Lee SY, Sung IK, Park HS, Yoo MW, Lee KY. High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma. J Cancer Res Clin Oncol 2010;136:1929-35. [PMID: 20306088 DOI: 10.1007/s00432-010-0852-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
87 Lee SJ, Lee WW, Yoon HJ, Lee HY, Lee KH, Kim YH, Park DJ, Kim HH, So Y, Kim SE. Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer. Eur J Radiol 2013;82:935-42. [PMID: 23410909 DOI: 10.1016/j.ejrad.2013.01.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
88 Kwon JH, Ryu SW, Kang YN. Traumatic neuroma around the celiac trunk after gastrectomy mimicking a nodal metastasis: a case report. Korean J Radiol 2007;8:242-5. [PMID: 17554193 DOI: 10.3348/kjr.2007.8.3.242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
89 Yang DM, Kim HC, Jin W, Ryu CW, Kang JH, Park CH, Kim HS, Jung DH. 64 multidetector-row computed tomography for preoperative evaluation of gastric cancer: histological correlation. J Comput Assist Tomogr 2007;31:98-103. [PMID: 17259840 DOI: 10.1097/01.rct.0000234072.16209.ab] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
90 Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Inoue T. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey. Jpn J Radiol 2014;32:253-9. [DOI: 10.1007/s11604-014-0294-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
91 Hayes T, Smyth E, Riddell A, Allum W. Staging in Esophageal and Gastric Cancers. Hematology/Oncology Clinics of North America 2017;31:427-40. [DOI: 10.1016/j.hoc.2017.02.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
92 Staniuk T, Małkowski B, Śrutek E, Szlęzak P, Zegarski W. Comparison of FLT-PET/CT and CECT in gastric cancer diagnosis. Abdom Radiol (NY) 2016;41:1349-56. [PMID: 26826089 DOI: 10.1007/s00261-016-0647-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
93 Liyanaarachchi MR, Shimazoe K, Takahashi H, Nakagawa K, Kobayashi E, Sakuma I. Development and evaluation of a prototype detector for an intraoperative laparoscopic coincidence imaging system with PET tracers. Int J Comput Assist Radiol Surg 2021;16:29-39. [PMID: 33159670 DOI: 10.1007/s11548-020-02282-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Namikawa T, Okabayshi T, Nogami M, Ogawa Y, Kobayashi M, Hanazaki K. Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer. Int J Clin Oncol 2014;19:649-55. [PMID: 23877653 DOI: 10.1007/s10147-013-0598-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
95 Ott K, Lordick F, Blank S, Büchler M. Gastric cancer: surgery in 2011. Langenbecks Arch Surg 2011;396:743-58. [PMID: 21234760 DOI: 10.1007/s00423-010-0738-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
96 Gu J, Yamamoto H, Fukunaga H, Danno K, Takemasa I, Ikeda M, Tatsumi M, Sekimoto M, Hatazawa J, Nishimura T, Monden M. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 2006;51:2198-205. [PMID: 17080242 DOI: 10.1007/s10620-006-9428-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
97 Filik M, Kir KM, Aksel B, Soyda Ç, Özkan E, Küçük ÖN, İbiş E, Akgül H. The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer. Mol Imaging Radionucl Ther 2015;24:15-20. [PMID: 25800593 DOI: 10.4274/mirt.26349] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
98 Aichler M, Luber B, Lordick F, Walch A. Proteomic and metabolic prediction of response to therapy in gastric cancer. World J Gastroenterol. 2014;20:13648-13657. [PMID: 25320503 DOI: 10.3748/wjg.v20.i38.13648] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
99 Altini C, Niccoli Asabella A, Di Palo A, Fanelli M, Ferrari C, Moschetta M, Rubini G. 18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography. Medicine (Baltimore). 2015;94:e864. [PMID: 25997066 DOI: 10.1097/MD.0000000000000864] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
100 Mukai K, Ishida Y, Okajima K, Isozaki H, Morimoto T, Nishiyama S. Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer. 2006;9:192-196. [PMID: 16952037 DOI: 10.1007/s10120-006-0374-7] [Cited by in Crossref: 106] [Cited by in F6Publishing: 86] [Article Influence: 7.6] [Reference Citation Analysis]
101 Kamimura K, Nagamachi S, Wakamatsu H, Fujita S, Nishii R, Umemura Y, Ogita M, Komada N, Sakurai T, Inoue T, Fujimoto T, Nakajo M. Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET. Nucl Med Commun 2009;30:431-9. [PMID: 19352209 DOI: 10.1097/MNM.0b013e3283299a2f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
102 Redondo-Cerezo E, Martínez-Cara JG, Jiménez-Rosales R, Valverde-López F, Caballero-Mateos A, Jérvez-Puente P, Ariza-Fernández JL, Úbeda-Muñoz M, López-de-Hierro M, de Teresa J. Endoscopic ultrasound in gastric cancer staging before and after neoadjuvant chemotherapy. A comparison with PET-CT in a clinical series. United European Gastroenterol J 2017;5:641-7. [PMID: 28815027 DOI: 10.1177/2050640616684697] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
103 Gabriel E, Attwood K, Narayanan S, Brady M, Nurkin S, Hochwald S, Kukar M. Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma? J Surg Oncol 2018;117:659-70. [DOI: 10.1002/jso.24894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
104 Erasmus JJ, Rohren EM, Hustinx R. PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers. PET Clinics 2008;3:135-45. [DOI: 10.1016/j.cpet.2008.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
105 Findlay JM, Antonowicz S, Segaran A, El Kafsi J, Zhang A, Bradley KM, Gillies RS, Maynard ND, Middleton MR. Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery. Eur Radiol 2019;29:2490-8. [PMID: 30643947 DOI: 10.1007/s00330-018-5904-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
106 Guo JW, Zhang XT, Chen XS, Zhang XC, Zheng GJ, Zhang BP, Cai YF. Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: a case report. World J Gastroenterol 2014;20:2120-6. [PMID: 24587686 DOI: 10.3748/wjg.v20.i8.2120] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]